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ABSTRACT 
Objective: To evaluate the decrease of liver function after treatment of antituberculosis drugs-fixed doses combination (ATD-FDC) category 1 in 
tuberculosis patients with malnutrition and alcohol consumption. 
Methods: This was an experimental study, with a quasi-experimental pretest and posttest design, to evaluate the increase in SGPT in pulmonary TB 
patients with malnutrition, treated with ATD-FDC for 8 w. Inclusion criteria were: pulmonary TB patients, aged ≥ 18 y old, who would receive ATD-
FDC category 1 treatment, did not have an increase in SGPT level at the beginning of the treatment and were willing to join the study. This study was 
conducted in all community health centers in Kupang, Indonesia. 
Results: The result of this study showed that percentage of SGPT level is increased after treatment of ATD-FDC compared with before treatment in 
TB patient with malnutrition compared with TB patients without malnutrition (135.1% vs. 54.7%; p<0.001). The difference of SGPT level in TB 
patients ≥40 y versus<40 y was 15.5 IU/l versus 9.1 IU/l (p<0.05). The difference of SGPT level in TB patient ≥40 y with routine alcohol 
consumption habit compared with non-routine alcohol consumption was 29.3 IU/l vs. 12.8 IU/l (p<0.01). 
Conclusion: Pulmonary TB patients with malnutrition had a larger decrease in liver function after treatment with ATD-FDC category 1 for 8 w, 
compared to those without malnutrition. Routine alcohol consumption had an effect on the increase in SGPT level in older patients. 
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INTRODUCTION 
Tuberculosis (TB) is an important global public health problem, and 
until recently, it has become the attention of various countries in the 
world. In Indonesia, TB is a major problem in public health. A total 
number of TB patients in Indonesia is on the highest five in the 
world, after India, China, South Africa and Nigeria [1]. 
The effectivity of TB drugs is the main health issue in various 
countries in the world. It is affected mainly by the adherence of the 
patients, multidrug resistance, and unfavorable drug adverse effects 
[2]. Antituberculosis drugs (ATD) have adequately high affectivity, 
with acceptable toxicity level; however, these drugs given in 
combination may lead to serious adverse effects. Possible adverse 
effects include hepatitis (jaundice) without other causes, pruritus 
and skin redness, balance disorder, deafness, gastrointestinal 
disorder, eye disorder, purpura and shock [3-4]. 
Three drugs in the treatment of TB, namely, isoniazid, pyrazinamide, 
and rifampicin, have the potential to cause hepatotoxicity, which can 
progress into drug-associated hepatitis. Hepatotoxicity interaction 
between isoniazid and rifampicin may be associated with the 
additive or synergistic effects [5-6]. 
Villar et al. reported that the risk of drug-induced hepatitis was 
18.2% in patients who had risk factors for old age, chronic liver 
disease, alcohol/other drugs abuse, or malnutrition, and 5.8% in 
patients without the risk factors [7]. Incidence of antituberculosis 
drug-induced hepatitis (anti-TB-DIH) is the most serious adverse 
effect and has a potential to be fatal, particularly with the risk factors 
such as age, female gender, slow acetylation status, alcohol 
consumption habit, malnutrition, hypoalbuminemia, human 
immunodeficiency virus (HIV) positive patients and previous liver 
diseases [5, 8-10]. Several other studies reported that malnutrition 
did not affect the occurrence of anti-TB-DIH, and did not affect the 
metabolism of isoniazid and rifampicin in the body [11-12]. 
Nusa Tenggara Timur (NTT) Province is an area with a relatively 
high TB prevalence. A total number of pulmonary TB with acid-fast 
bacilli (+) detected in 2010 in NTT Province was 3,708 cases, of 
which there were 3,222 cases treated, with the cure rate was up to 
70.7%. Data from Indonesian Ministry of Health in 2013 showed 
that TB case notification rate per 100,000 people in NTT was 90, 
with a success rate of 94.56% [13]. 
Prevalence of malnutrition among TB patients in NTT is very high. 
There are 87% TB patients in NTT who have malnutrition, and 
average body mass index (BMI) of TB patients were 16.1, lower than 
the average BMI in healthy people [14]. The prevalence of 
malnutrition in TB patients in Yogyakarta were only 41.9%, with the 
average BMI of 18.4 [12]. A study in Jakarta also showed the 
prevalence of malnutrition in TB patients were 66% [15]. 
Malnutrition increases the risk of TB, and in turn, TB causes 
malnutrition. Malnutrition is commonly found in people with TB and 
a predictor of mortality and TB recurrence [16]. 
Half of the NTT population also had alcohol consumption habit. This 
habit has an unfavorable effect on the body. It may cause malnutrition, 
as well as increases the risk of hepatotoxicity in TB patients who were 
treated with the antituberculosis drugs–fixed dose combination (ATD-
FDC) [17]. Therefore, this study was aimed to evaluate the decrease of 
liver function after treatment of antituberculosis drugs-fixed doses 
combination (ATD-FDC) category 1 in tuberculosis patients with 
malnutrition and alcohol consumption. 
MATERIALS AND METHODS 
This was an experimental study, with a quasi-experimental pretest and 
posttest design, to evaluate the increase in SGPT in pulmonary TB 
patients with malnutrition, treated with ATD-FDC for 8 w. This study 
protocol has received ethical clearance from the ethics c ommittee in 
Biomedical Research on Human in GadjahMada University. 
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Cases were collected with consecutive sampling technique, which 
means that all cases satisfied the inclusion and exclusion criteria 
may be included as samples in this study until sample size needed 
was fulfilled. The sample size was calculated with Lemeshow 
formula, and we need a minimum of 72 patients. Inclusion criteria 
were: pulmonary TB patients, aged ≥ 1 8 y old, who would receive 
ATD-FDC category 1 treatment, did not have an increase in SGPT 
level at the beginning of the treatment and were willing to join the 
study. This study was conducted in all community health centers in 
Kupang district, NTT province, Indonesia. 
History taking, physical examination and laboratory examination (SGPT 
and bilirubin) were conducted to each subject at the beginning before 
the treatment, and after 8 w treatment. Estimation was made by 
enzymatic and spectrophotometric methods, respectively. A decrease in 
liver function was shown when the patients had the symptoms of 
nausea, vomiting, or abdominal pain, with jaundiced sclera, or an 
increase in SGPT over the upper limit of normal value, or urinary 
bilirubin positive. Malnutrition was assessed by the measurement of 
body mass index (BMI)<18.5 kg/m2. BMI was calculated by dividing the 
body weight (kg) by the square of body height (m2
RESULTS 
). Statistical analysis 
was done by independent t-test and paired t-test. 
TB patients who fulfilled the inclusion criteria and included as the 
subjects of this study were 74 patients, but only 72 patients who 
completed the study and could be analyzed. Two of them died 
during treatment.  
The average age of subjects was 35.1 y, with a minimum age of 18 y 
and maximum age of 70 y. The proportion of the older patients ( ≥ 40 
y) was 33.3% (24 patients) and the younger patients (<40 y) was 
66.7% (48 patients). 
 
Table 1: Characteristics of all pulmonary TB patients who received ATD-FDC category 1 for 8 w 
Variables  n (%) 
Age (years) 
- Older (≥ 40 y) 





Gender (%)   
- Male  46/72 (63.9) 
- Female   26/72 (36.1) 
Body weight (kg) 42.54±6.74  
Body height (cm) 160.22±7.47  
Body mass index (mean±SD) 16.53±2.07  
Nutritional status based on BMI   
- No malnutrition  10/72 (13.9) 
- Malnutrition  62/72 (86.1) 
Alcohol consumption habit:    
- Yes  31/72 (43.06) 
- No  41/72(56.94) 
Routine alcohol consumption habit:    
- Yes  14/72 (19.44) 
- No  58/72 (80.56) 
Drug dose   
- 2 tablets  14/72 (19.44) 
- 3 tablets or more  58/72 (80.56) 
Value are expressed as mean+SD 
 
The proportion of male subjects was 63.9% (46 patients), and that of 
a female was 36.1% (26 patients). The average BMI was low, around 
16.5, and the proportion of subjects with malnutrition was 86.1%. 
The proportion of subjects with alcohol consumption habit was 
43.06% while those with routine alcohol consumption habit were 
19.44%. There were 19.44% subjects who received 2 tablets, and 
80.56% who received 3 tablets or more. In this study, total patients 
who were older (≥ 4 0 y) and had malnutrition were 18. Out of 18 
patients, those who had alcohol consumption habit was 38.89% (7 
patients).
 
Table 2: SGPT level before and after receiving ATD-FDC treatment for 8 w in pulmonary TB patients 
Variables SGPT before treatment (IU/l) SGPT after treatment (IU/l) 
Age   
- All (n-=72) 
- Older (≥ 40 y) (n=24) 







Gender   
- Male (n=46) 





Malnutrition   
- Yes (n=62) 





Alcohol consumption habit:    
- Yes (n=31) 





Routine alcohol consumption   
- Yes (n=14) 





Drug dose   
- 3 tablets or more (n=58) 





The analysis was conducted with paired T-test. Value are expressed as mean+SD, * p<0.05, *** p<0.001.  
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In this study, there was a statistically significant difference in average SGPT level before and after ATD-FDC category 1 treatment in all subjects. 
 
Table 3: Increase in SGPT level in TB patients treated with ATD-FDC category 1 for 8 w 
Variables Increase in SGPT level (IU/l) 
Age  
- Older (≥ 40 y) (n=24) 




- Male (n=46) 




- Yes (n=62) 
- No (n=10 
11.3±13.2 
11.0±12.0 
Alcohol consumption habit:   
- Yes (n=31) 
- No (n=41) 
10.1±14.0 
12.1±12.2 
Routine alcohol consumption  
- Yes (n=14) 
- No (n=58) 
11.4±18.2 
11.2±11.6 
Drug dose  
- 3 tablets or more (n=58) 
- 2 tablets (n=14) 
11.6±12.5 
9.9±15.2 
The analysis was conducted with independent T-test. Value are expressed as mean+SD, p*<0.05.  
 
The average increase in SGPT level in older subjects was 15.5 while that 
in the younger subjects was 9.1. In older patients, average first SGPT 
level was 19.5 and average second SGPT level was 35.1. In younger 
patients, average first SGPT level was 19.9 and average second SGPT 
level was 29.0. Analysis showed that there was an age effect on the 
increase in SGPT level in TB patients treated with ATD-FDC category 1 
for 8 w because there was a statistically significant difference in the 
average increase in SGPT level between the older and younger age. 
 
Table 4: Difference in SGPT level stratified by age in patients with malnutrition and without malnutrition 
Variables Difference in SGPT level (IU/l) 
TB patients with malnutrition  
• Older (≥ 40 y) (n=14) 
• Younger (<40 y) (n-44) 
17.3±12.2* 
8.8±13.0* 
TB patients without malnutrition  
• Older (≥ 40 y) (n=6) 
• Younger (<40 y) (n=4) 
10.2±13.6 
12.3±11.0 
The analysis was conducted with independent T-test. Value are expressed as mean+SD, * p<0.05.  
 
In malnutrition-patients, the average increase in SGPT level for older 
patients (≥ 40 y) was 17.3, while that for younger patients (<40 y) 
was 8.8. This difference was statistically significant. In patients 
without malnutrition, the average increase in SGPT level in older 
patients (≥ 40 y) was 10.2, while that in younger patients (<40 y) 
was 12.3, but there was no statistically significant difference. 
Average increase in SGPT level in male subjects was 11.4 while that 
in female subjects was 11.1. Analysis showed that gender did not 
affect the average increase in SGPT level because there was no 
statistically significant difference in the average increase of SGPT 
level between males and females. 
In this study, most subjects had malnutrition (86.1%). The average 
increase in SGPT level in patients with malnutrition was 11.3 while 
the average increase in SGPT level in patients without malnutrition 
was lower (11.0). Analysis showed that the average increase in SGPT 
level was higher in malnutrition-patients, but this difference was not 
statistically significant. 
 
Table 5: Percentage of increase in SGPT level compared to the SGPT level before treatment with ATD-FDC category 1 for 8 w in TB patients 
with malnutrition and without malnutrition 
Variables % increase SGPT level compared with initial SGPT level 
TB patients  
- With malnutrition (n=62) 
- Without malnutrition (n=10) 
135.05±117.45*** 
54.69±37.66*** 
The analysis was conducted with independent T-test. *** p<0.001.  
 
The average percentage of the increase in SGPT level compared to the 
initial SGPT level in patients with malnutrition was 135.1%, and that 
in patients without malnutrition was 54.7%. This difference was 
statistically significant. The average difference in SGPT level in patients 
who had alcohol consumption habit was 10.1 while the average in 
patients who did not have alcohol consumption habit was 12.1. This 
difference was not statistically significant. The average of the 
difference in SGPT level in patients who had routine alcohol 
consumption habit was 11.4, while that for patients who did not have 
the habit was 11.2. This difference was not statistically significant. 
 
Febianti et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 7, 269-273 
272 
Table 6: Difference in SGPT level before and after treatment with ATD-FDC category 1 for 8 w in older (≥ 40 y) TB patients stratified by 
alcohol consumption habit 
Variables Difference in SGPT level (IU/l) 
Older (≥ 40 y) TB patients  
• Alcohol consumption (+) (n=11) 
• Alcohol consumption (-) (n=13) 
14.7±15.4 
16.2±10.4 
Older (≥ 40 y) TB patients  
• Routine alcohol consumption (+) (n=4) 
• Routine alcohol consumption (-) (n=20) 
 29.3±10.6** 
12.8±11.3** 
The analysis was conducted with independent T-test. Value are expressed as mean+SD, ** p<0.01 
 
In older patients, the average increase in SGPT level in patients who 
had alcohol consumption habit was 14.7, and in those without the 
habit was 16.2. In older patients who had routine alcohol 
consumption habit, the average increase in SGPT level was 29.3, and 
in those without the habit 12.8. From the analysis, routine alcohol 
consumption had an effect on the increase in SGPT level in older 
patients, because there was a significant difference between older 
patients who had routine alcohol consumption habit and those 
without the habit. 
In this study, most patients took 3 ATD-FDC tablets or more. In those 
patients who took 3 ATD-FDC tablets or more, the average 
difference in SGPT level was 11.6, while in those who took 2 tablets, 
the average difference was 9.9. There was no statistically significant 
difference in the average of the difference in SGPT level in patients 
who took 2 tablets or 3 tablets or more. 
From urinary bilirubin examination, the results were negative in all 
subjects, both before treatment with ATD-FDC category 1 and after 
the treatment for 8 w. Based on these results, there was an increase 
in SGPT level before and after the treatment with ATD-FDC category 
1 for 8 w, but this did not increase the urinary bilirubin level. 
DISCUSSION 
In this study, there was an increase in SGPT level after the treatment 
with ATD-FDC category 1 for 8 w, because there was a statistically 
significant difference in SGPT level before and after the treatment. 
This is in line with the previous study that showed a decrease in 
liver function after ATD drugs treatment [3, 18]. 
Analysis showed that gender did not affect the increase in SGPT level 
in this study, because there was no statistically significant difference 
between the average in the increase of SGPT level between males 
and females, although there was a significant difference between the 
average SGPT level before and after the treatment in the whole 
subjects. These results are consistent with several previous studies 
which showed that there was no difference in the increase in serum 
transaminase level between male and female subjects [5, 9, 12]. 
However, these results are different from the study by Shakya, 
which suggested that female gender was a predisposing factor of 
hepatotoxicity induced by ATD [19]. 
The study by Makhlouf in Mesir included more females (56%) than 
males. This case-control study had a sample size of 100 patients [9]. 
Meanwhile, the study by Shakya was conducted in Nepal, using 
cohort study design with 50 subjects [19]. 
The results are consistent with previous studies which showed that the 
proportion of male TB patients were larger than females [5, 19-20]. 
Analysis showed that age had an effect on the increase in SGPT level 
in TB patients who were treated with ATD-FDC category 1 for 8 w. 
This is similar to the previous studies which suggested that there 
was an effect of age on the increase in serum transaminase level [10-
11]. Meanwhile, a study by Febrinasari showed that age did not 
affect the increase in serum transaminase level [12]. 
The results are in line with several previous studies which showed 
that there was no difference in the increase in transaminase level 
between male and female subjects [5, 9, 12]. However, this is 
different from the study by Shakya, which stated that female gender 
was the predisposing factor of hepatotoxicity induced by ATD [20].  
Analysis showed that malnutrition affected the decrease in liver 
function in TB patients treated with ATD-FDC category 1 for 8 w. 
This is consistent with the previous studies which suggested that 
malnutrition was a risk factor of hepatotoxicity in TB patients who 
were treated with ATD drugs [5, 10, 21]. However, this is contrasted 
with the study by Febrinasari, who showed that malnutrition did not 
affect the increase in serum transaminase level [12]. 
The results are similar with the previous study that suggested that 
high dose alcohol consumption affected hepatotoxicity in TB 
patients who were treated with ATD drugs [7, 11]. Nevertheless, the 
results differ from the results of the study by Singh et al. who stated 
that alcohol consumption habit was not a risk factor of 
hepatotoxicity in TB patients who were treated with ATD [5]. 
From the analysis, it was shown that drug dose did not affect the 
increase in SGPT level. This is in line with the study by Febrinasari in 
Yogyakarta, which showed that there was no effect of drug dose on 
the increase in SGPT level in TB patients who were treated with 
ATD-FDC category 1 [12]. 
Analysis showed that there was an effect of malnutrition on the decrease 
in liver function in TB patients who were treated with ATD-FDC category 
1 for 8 w. This is in line with the previous studies which showed that 
malnutrition was a risk factor of hepatotoxicity in TB patients who were 
treated with ATD [5, 10, 21]. This differs from the results from 
Febrinasari study that suggested that malnutrition did not affect the 
increase in serum transaminase level [12]. 
A study by Singh was conducted in India. India is a country with a 
high prevalence rate of TB. In the study, malnutrition was measured 
similarly as the measurement in this study, namely, using BMI<18.5. 
Average BMI of subjects in Singh study was 17.2. It was a case-
control study conducted on 120 TB patients [5]. 
The result of this study was similar with that of Singh study in India. 
This is likely due to the similarity in locations of the study, which have 
high TB prevalence with a low average of BMI. Therefore, there is a 
possibility that there has been a decrease in liver function caused by 
malnutrition [5]. Limitations of this study were not conducted 
screening pre-albumin levels to see malnutrition in early studies 
CONCLUSION 
Pulmonary TB patients with malnutrition had a larger decrease in liver 
function after treatment with ATD-FDC category 1 for 8 w, compared 
to those without malnutrition. Routine alcohol consumption had an 
effect on the increase in SGPT level in older patients 
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